neoplasm. c97
Conditions
Interventions
In the first cycle of the study, patients received one of the antiemetic regimen, regimen A (routine + 1 gr ginger ) or regimen B (routine +1gr Placebos)
Intervention 1: In the first cycle of the study, patients received one of the antiemetic regimen, regimen A (routine + 1 gr ginger ) or regimen B (routine +1gr Placebos). Intervention 2: In the next
Treatment - Drugs
In the next cycle of chemotherapy , 28 days after the previous cycle another regimen (A or B ) administrated together with chemotherapy drugs
Sponsors
vice chancellor for research , Guilan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Inclusion criteria: age more than 18 years old, having experience of chemotherapy along with nausea and vomit, having minimum two chemotherapy periods containing of 50-100 milligram per square meter of sys-platinum, individually or along with other factors of chemotherapy with the similar amount and method of prescription in two chemotherapy cycles without any plan for radiotherapy between two cycles, Remaining in the ward for a period of 24 hours (in order to study of the PRN anti-nausea drugs), Not having nausea and vomit for reasons other than chemotherapy, non-receiving anti-nausea and anti-vomit drugs during the past 24 hours, not receiving treatment with Corticosteroid Drugs during the studied cycles, not-suffering from Hepatitis, obstruction of digestion system, cerebral malignancy or cerebral metastasis and coagulation disorders (plaque less than 100000 per cubic millimeter) based on the registered information in the file and not consuming any anti-coagulation drug. Exclusion criteria: radiothearpy during research, severe nausea and vomiting, not able to eat capsule, stop chemotherapy for any reasons, sever gastroenteritis
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Nausae and vomiting. Timepoint: 1, 2, 3, 4, 24 hours. Method of measurement: cheklist. | — |
Secondary
| Measure | Time frame |
|---|---|
| Nausea and vomiting. Timepoint: 28 days after first dose drugs , (change regime A,B) and after that for 1, 2,3,4 and 24 after that , nause and vomit was assessed. Method of measurement: cortilla tool. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAtefeh Ghanbari
Guilan University of Medical Sciences
Outcome results
None listed